TGFB1 and neoplasm: Furthermore, IL‐6, IL‐7, IL‐8, and TGF‐β1 Abs (10 μg/mouse twice times per week, i.v.)markedly inhibited activated CAFs‐induced KYSE30 tumor malignancy in vivo (Figure 9A and B).